Pura Vida Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Pura Vida Investments’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Hold	0	–	–	–	200
2022 Q2	–	Hold	0	–	–	–	210
2022 Q1	–	Sell	-50,000	Closed	-$1.21M	–	229
2021 Q4	$1.17M	Buy	+50,000	New	+$1.01M	0.12%	169
2021 Q2	–	Hold	0	–	–	–	222
2021 Q1	–	Hold	0	–	–	–	219
2016 Q4	–	Sell	-123,066	Closed	-$3.92M	–	70
2016 Q3	$3.92M	Buy	+123,066	New	+$4.17M	1.58%	33
2016 Q2	–	Hold	0	–	–	–	78
2016 Q1	–	Hold	0	–	–	–	78

Other funds holding ACAD

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return